Skip to content

Evaluation of hair growth effects by application of hair lotion containing lactic-acid bacteria

Evaluation of hair growth effects by application of hair lotion containing lactic-acid bacteria - Evaluation of hair growth effects by application of hair lotion containing lactic-acid bacteria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044792
Enrollment
100
Registered
2021-08-20
Start date
2021-08-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Apply lactic acid bacteria-containing lotion for 24 weeks Apply the placebo lotion for 24 weeks

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged 20 to 59 years old at the time of informed consent 2) Subjects who are aware of their thinning hair 3) Subjects who can consent to have their hair partially cut by a hairdresser 4) Subjects who can consent not to change their hair conditioning method (hair length, hair style, perm, etc.), hair dyeing method and hair washing method

Exclusion criteria

Exclusion criteria: 1) Subjects who can be allergic to ingredients of the test product 2) Subjects who are taking/applying medicines for hair growth that can affect the test result 3) Subjects who are taking supplements for hair growth that can affect the test result 4) Subjects who have sensitive skin or possibility of allergy to the test product 5) Subjects who currently go to the dermatology 6) Pregnant or breastfeeder. Those who desire pregnancy and lactation 7) Subjects who participate in other clinical trials 8) Subjects who are using shampoo/conditioner for hair growth 9) Subjects with underlying medical conditions such as diabetes, chronic respiratory disease, chronic heart disease, hypertension, chronic kidney disease, chronic liver disease, chronic blood disease, neurological disease, neuromuscular disease, chromosomal abnormalities and severe psychosomatic disorders 10) Subjects who are taking medical treatments

Design outcomes

Primary

MeasureTime frame
Phototrichogram (number of hairs at anagen and telogen, number of hairs, hair diameter, ratio of softened hairs and non-softened hairs, hair growth coefficient) at 0-12-24w

Countries

Japan

Contacts

Public ContactKo Masuda

SOUKEN Co., Ltd Management Division

k_masuda@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026